Clinical Trial Update: Kisspeptin Administration in the Adult [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating Kisspeptin administration in adults with hypogonadotropic hypogonadism and related GnRH deficiencies, including Kallmann syndr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gonadotropin-releasing Hormone Deficiency
• Hyperprolactinemia
• Hypogonadotropic Hypogonadism
• Kallmann Syndrome
• Polycystic Ovary Syndrome

Drugs mentioned

• Kisspeptin-54 (Kisspeptin-54)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Hypogonadotropic Hypogonadism, Kallmann Syndrome | Phase 1 | Status: COMPLETED